InsiderFlow

Fred Aslan

ARTV

Fred Aslan serves as director, officer: Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

11 trades

$2.41M

Net Position

Net Seller

$2.41M

Companies Traded

1

ARTV

Active Period

May 2025 – Nov 2026

11 total trades

Most Recent

Sell ARTV

Nov 3, 2026 · $260.0K

Fred Aslan's Insider Trading at Artiva Biotherapeutics, Inc. (ARTV)

Buys

0 · $0.00

Sells

11 · $2.41M

Total Shares Bought

0

Total Shares Sold

350,223

ARTV Price Chart
Loading chart...
DateTypeValue
Nov 3, 2026 Sell$260.0K
Oct 7, 2026 Sell$168.9K
Oct 6, 2026 Sell$421.8K
Sep 9, 2026 Sell$255.7K
Sep 4, 2026 Sell$690.4K
May 19, 2026 Sell$244.3K
Feb 15, 2026 Sell$58.4K
Dec 15, 2025 Sell$19.1K
Nov 15, 2025 Sell$42.1K
Oct 17, 2025 Sell$153.0K
May 15, 2025 Sell$91.4K